Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023

Author's Avatar
Feb 16, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the fourth quarter and fiscal year 2022 on Thursday, March 2, 2023, at 6:30 a.m. (ET).